TELA - NASDAQ

TELA Bio, Inc.

TELA·NASDAQ

$1.14

+0.44%

HealthcareMedical - Devices

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$50.78M

EPS-0.8300

P/E Ratio-1.37

Earnings Date05/06/2026

tela

Short Term Debt

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

TELA Bio, Inc. Competitors Analysis of Short Term Debt

TELA · NASDAQ

Company	Short Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
TELA Bio, Inc. NASDAQ:TELA	0.00	N/A	N/A	N/A
Coeptis Therapeutics, Inc. NASDAQ:COEP	118.88K	-51.0%	-45.3%	N/A
Equillium, Inc. NASDAQ:EQ	363.00K	N/A	-24.0%	N/A
Spectral AI, Inc. NASDAQ:MDAI	3.59M	101.9%	43.8%	N/A
Outlook Therapeutics, Inc. NASDAQ:OTLK	58.90B	1083.3%	817.8%	154.3%
Spruce Biosciences, Inc. NASDAQ:SPRB	0.00	N/A	N/A	N/A
Biodesix, Inc. NASDAQ:BDSX	1.37M	199.5%	135.3%	N/A
Pulmonx Corporation NASDAQ:LUNG	1.32M	-15.2%	70.6%	N/A
Cytosorbents Corporation NASDAQ:CTSO	0.00	N/A	N/A	N/A
Cue Biopharma, Inc. NASDAQ:CUE	0.00	N/A	N/A	N/A
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	316.00K	-67.4%	-9.4%	N/A

TELA Bio, Inc. Fair Value Envelope

TELA · NASDAQ

Our analysis suggests that TELA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.135, this represents a potential HIDDEN relative to our calculated worth for TELA Bio, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.135

Related Guides

Blog Categories

Continue your TELA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.